These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
437 related articles for article (PubMed ID: 34440785)
21. Keratin Hydrogel Enhances In Vivo Skeletal Muscle Function in a Rat Model of Volumetric Muscle Loss. Passipieri JA; Baker HB; Siriwardane M; Ellenburg MD; Vadhavkar M; Saul JM; Tomblyn S; Burnett L; Christ GJ Tissue Eng Part A; 2017 Jun; 23(11-12):556-571. PubMed ID: 28169594 [TBL] [Abstract][Full Text] [Related]
22. Volumetric Muscle Loss: A Bibliometric Analysis of a Decade of Progress. Kulwatno J; Goldman SM; Dearth CL Tissue Eng Part B Rev; 2023 Jun; 29(3):299-309. PubMed ID: 36475848 [TBL] [Abstract][Full Text] [Related]
23. Neutrophil and natural killer cell imbalances prevent muscle stem cell-mediated regeneration following murine volumetric muscle loss. Larouche JA; Fraczek PM; Kurpiers SJ; Yang BA; Davis C; Castor-Macias JA; Sabin K; Anderson S; Harrer J; Hall M; Brooks SV; Jang YC; Willett N; Shea LD; Aguilar CA Proc Natl Acad Sci U S A; 2022 Apr; 119(15):e2111445119. PubMed ID: 35377804 [TBL] [Abstract][Full Text] [Related]
24. Regenerative medicine for skeletal muscle loss: a review of current tissue engineering approaches. Langridge B; Griffin M; Butler PE J Mater Sci Mater Med; 2021 Jan; 32(1):15. PubMed ID: 33475855 [TBL] [Abstract][Full Text] [Related]
25. Laminin-111-Enriched Fibrin Hydrogels Enhance Functional Muscle Regeneration Following Trauma. Ziemkiewicz N; Hilliard GM; Dunn AJ; Madsen J; Haas G; Au J; Genovese PC; Chauvin HM; West C; Paoli A; Garg K Tissue Eng Part A; 2022 Apr; 28(7-8):297-311. PubMed ID: 34409846 [TBL] [Abstract][Full Text] [Related]
27. Pharmacological Mitigation of Fibrosis in a Porcine Model of Volumetric Muscle Loss Injury. Corona BT; Rivera JC; Dalske KA; Wenke JC; Greising SM Tissue Eng Part A; 2020 Jun; 26(11-12):636-646. PubMed ID: 31856683 [TBL] [Abstract][Full Text] [Related]
28. Pharmaceutical Agents for Contractile-Metabolic Dysfunction After Volumetric Muscle Loss. McFaline-Figueroa J; Schifino AG; Nichenko AS; Lord MN; Hunda ET; Winders EA; Noble EE; Greising SM; Call JA Tissue Eng Part A; 2022 Sep; 28(17-18):795-806. PubMed ID: 35620911 [TBL] [Abstract][Full Text] [Related]
29. An acellular biologic scaffold does not regenerate appreciable de novo muscle tissue in rat models of volumetric muscle loss injury. Aurora A; Roe JL; Corona BT; Walters TJ Biomaterials; 2015 Oct; 67():393-407. PubMed ID: 26256250 [TBL] [Abstract][Full Text] [Related]
30. Transplantation of devitalized muscle scaffolds is insufficient for appreciable de novo muscle fiber regeneration after volumetric muscle loss injury. Garg K; Ward CL; Rathbone CR; Corona BT Cell Tissue Res; 2014 Dec; 358(3):857-73. PubMed ID: 25300647 [TBL] [Abstract][Full Text] [Related]
31. Further development of a tissue engineered muscle repair construct in vitro for enhanced functional recovery following implantation in vivo in a murine model of volumetric muscle loss injury. Corona BT; Machingal MA; Criswell T; Vadhavkar M; Dannahower AC; Bergman C; Zhao W; Christ GJ Tissue Eng Part A; 2012 Jun; 18(11-12):1213-28. PubMed ID: 22439962 [TBL] [Abstract][Full Text] [Related]
32. Repairing Volumetric Muscle Loss with Commercially Available Hydrogels in an Ovine Model. Su EY; Kennedy CS; Vega-Soto EE; Pallas BD; Lukpat SN; Hwang DH; Bosek DW; Forester CE; Loebel C; Larkin LM Tissue Eng Part A; 2024 May; 30(9-10):440-453. PubMed ID: 38117140 [TBL] [Abstract][Full Text] [Related]
33. Identifying dysregulated immune cell subsets following volumetric muscle loss with pseudo-time trajectories. Hymel LA; Anderson SE; Turner TC; York WY; Zhang H; Liversage AR; Lim HS; Qiu P; Mortensen LJ; Jang YC; Willett NJ; Botchwey EA Commun Biol; 2023 Jul; 6(1):749. PubMed ID: 37468760 [TBL] [Abstract][Full Text] [Related]